Performance of the Abbott RealTime High-Risk HPV Test in Women With Abnormal Cervical Cytology Smears

被引:29
作者
Cuzick, Jack [1 ]
Ambroisine, Laurence [1 ]
Cadman, Louise [1 ]
Austin, Janet [1 ]
Ho, Linda [1 ]
Terry, George [1 ]
Liddle, Stuart [2 ]
Dina, Roberto [3 ,4 ]
McCarthy, Julie [5 ]
Buckley, Hilary [6 ]
Bergeron, Christine [7 ]
Soutter, W. P. [8 ,9 ]
Lyons, Deirdre
Szarewski, Anne [1 ]
机构
[1] Queen Mary Univ London, Wolfson Inst Prevent Med, Canc Res UK Ctr Epidemiol Math & Stat, London EC1M 6BQ, England
[2] Doctors Lab, London, England
[3] Hammersmith Hosp, Dept Cytopathol, London, England
[4] Queen Charlottes & Chelsea Hosp, Dept Cytopathol, London W6 0XG, England
[5] St Marys Hosp, Dept Cytopathol, London, England
[6] St Marys Hosp, Dept Pathol, Manchester M13 0JH, Lancs, England
[7] Lab Pasteur Cerba, Cergy Pontoise 9, France
[8] Hammersmith Hosp, Dept Gynaecol, London, England
[9] Queen Charlottes & Chelsea Hosp, Dept Gynaecol, London W6 0XG, England
关键词
HPV testing; cervical screening; Abbott RealTime high-risk HPV test; sensitivity; specificity; HUMAN-PAPILLOMAVIRUS DNA; INTRAEPITHELIAL NEOPLASIA; CONVENTIONAL CYTOLOGY; FOLLOW-UP; CANCER;
D O I
10.1002/jmv.21801
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HPV DNA testing is known to be much more sensitive than cytology, but less specific. A range of HPV and related tests in 858 women referred for colposcopy because of an abnormal smear were evaluated to compare the performances of these tests. This article compared the Abbott test to other tests which had been previously evaluated. This test was a real true test for 14 high-risk HPV types. The Abbott test was found to be highly sensitive for cervical intra-epithelial neoplasia grade 3 or worse (CIN3+) (98.9%) with a specificity of 31.5%. These numbers were comparable with the Qiagen HC2 test, the Roche Linear Array and Amplicor tests, and the Gen-Probe APTI MA test. Differences between these tests appeared to be related mostly to the choice of cutoff level. An added feature of the Abbott test was the provision of type specific results for HPV 16 and 18. J. Med. Virol. 82:1186-1191,2010. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:1186 / 1191
页数:6
相关论文
共 15 条
[1]   Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru [J].
Almonte, Maribel ;
Ferreccio, Catterina ;
Winkler, Jennifer L. ;
Cuzick, Jack ;
Tsu, Vivien ;
Robles, Sylvia ;
Takahashi, Rina ;
Sasieni, Peter .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (04) :796-802
[2]   Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial [J].
Bulkmans, N. W. J. ;
Berkhof, J. ;
Rozendaal, L. ;
van Kemenade, F. J. ;
Boeke, A. J. P. ;
Bulk, S. ;
Voorhorst, F. J. ;
Verheijen, R. H. M. ;
Groningen, Kvan ;
Boon, M. E. ;
Ruitinga, W. ;
van Ballegooijen, M. ;
Snijders, P. J. F. ;
Meijer, C. J. L. M. .
LANCET, 2007, 370 (9601) :1764-1772
[3]   Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening [J].
Bulkmans, NWJ ;
Rozendaal, L ;
Voorhorst, FJ ;
Snijders, PJF ;
Meijer, CJLM .
BRITISH JOURNAL OF CANCER, 2005, 92 (09) :1800-1802
[4]   Management of women who test positive for high-risk types of human papillomavirus: the HART study [J].
Cuzick, J ;
Szarewski, A ;
Cubie, H ;
Hulman, G ;
Kitchener, H ;
Luesley, D ;
McGoogan, E ;
Menon, U ;
Terry, G ;
Edwards, R ;
Brooks, C ;
Desai, M ;
Gie, C ;
Ho, L ;
Jacobs, I ;
Pickles, C ;
Sasieni, P .
LANCET, 2003, 362 (9399) :1871-1876
[5]   Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology - results from the Hammersmith study [J].
Cuzick, Jack ;
Szarewski, Anne ;
Mesher, David ;
Cadman, Louise ;
Austin, Janet ;
Perryman, Karen ;
Ho, Linda ;
Terry, George ;
Sasieni, Peter ;
Dina, Roberto ;
Soutter, William P. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) :2294-2300
[6]   Overview of the European and North American studies on HPV testing in primary cervical cancer screening [J].
Cuzick, Jack ;
Clavel, Christine ;
Petry, Karl-Ulrich ;
Meijer, Chris J. L. M. ;
Hoyer, Heike ;
Ratnam, Samuel ;
Szarewski, Anne ;
Birembaut, Philippe ;
Kulasingam, Shalini ;
Sasieni, Peter ;
Iftner, Thomas .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) :1095-1101
[7]   Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study [J].
Dillner, Joalim ;
Rebolj, Matejka ;
Birembaut, Philippe ;
Petry, Karl-Ulrich ;
Szarewski, Anne ;
Munk, Christian ;
de Sanjose, Silvia ;
Naucler, Pontus ;
Lloveras, Belen ;
Kjaer, Susanne ;
Cuzick, Jack ;
van Ballegooijen, Marjolein ;
Clavel, Christine ;
Iftner, Thomas .
BRITISH MEDICAL JOURNAL, 2008, 337 (7676) :a1754
[8]   The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice [J].
Khan, MJ ;
Castle, PE ;
Lorincz, AT ;
Wacholder, S ;
Sherman, M ;
Scott, DR ;
Rush, BB ;
Glass, AG ;
Shiffman, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1072-1079
[9]   Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer [J].
Mayrand, Marie-Helene ;
Duarte-Franco, Eliane ;
Rodrigues, Isabel ;
Walter, Stephen D. ;
Hanley, James ;
Ferenczy, Alex ;
Ratnam, Sam ;
Coutle, Francois ;
Franco, Eduardo L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16) :1579-1588
[10]   Human papillomavirus and papanicolaou tests to screen for cervical cancer [J].
Naucler, Pontus ;
Ryd, Walter ;
Tornberg, Sven ;
Strand, Anders ;
Wadell, Goran ;
Elfgren, Kristina ;
Radberg, Thomas ;
Strander, Bjorn ;
Forslund, Ola ;
Hansson, Bengt-Goran ;
Rylander, Eva ;
Dillner, Joakim .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16) :1589-1597